On December 26, 2023 Axcynsis Therapeutics reported that it is presenting at Biotech Showcase 2024 (Press release, Axcynsis Therapeutics, DEC 26, 2023, View Source [SID1234638793]). This year, registered attendees can view Axcynsis Therapeutics’ presentation live and access a recorded version beginning November 27th – SIX weeks before the event. With 24×7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Bin Zou will be presenting Axcynsis Therapeutics at the Biotech Showcase.
January 8th, 2024, at 2:45 pm Pacific time
Axcynsis Therapeutics is at the forefront of developing cutting-edge Antibody Drug Conjugate (ADC) therapies. It proudly announced its participation in the Biotech Showcase on January 8th, 2024, in San Francisco.
"We are honored to be presenting at the Biotech Showcase. Axcynsis Therapeutics is dedicated to developing the next generation of ADC platforms and drug candidates, and Axcynsis is uniquely positioned to tackle the substantial and urgent unmet needs in cancer therapeutics."
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during one of the industry’s largest gatherings and busiest weeks.
"We are delighted that Axcynsis Therapeutics will be joining us in San Francisco and presenting at Biotech Showcase this year," said Sara Demy, CEO of Demy-Colton. "Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery."